Sales growth changes of patented drugs in Canada 2022
This statistic displays the impacts on the annual sales growth of patented drugs which occurred during 2022. Exiting drug effects, loss of exclusivity, volume, and DAAs for Hepatitis C negatively impacted sales growth. The net change in sales during 2022 was an increase of 838 million Canadian dollars.